Latest News about ADAP
Recent news which mentions ADAP
Why Shares of Adaptimmune Therapeutics Jumped Tuesday
April 11, 2023
From Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
Why Is TCR2 Therapeutics Stock Trading Higher Today?
March 06, 2023
From Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 06, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
From Benzinga
From Benzinga
Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today?
March 06, 2023
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
From Benzinga
NXP Semiconductors, UBS Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 31, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
From Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
November 25, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022
November 09, 2022
From Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
From Benzinga
Why Adaptimmune Therapeutics Stock Is Glowing Green Today
November 08, 2022
Tickers
ADAP
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 25, 2022
From Benzinga
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day
October 25, 2022
From Benzinga
Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79%
October 04, 2022
From Benzinga
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
Adaptimmune's Cancer Candidate Shows 44% Response Rate In Pretreated Ovarian, Urothelial, Head & Neck Cancers
September 09, 2022
Tickers
ADAP
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 09, 2022
From Benzinga
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.